Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches. 2019

Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
Reference Center for Inborn Errors of Metabolism, INSERM U954,Nancy University Children's Hospital,54000 Nancy,France.

To provide a comprehensive systematic review of the literature by examining studies published on all cognitive aspects of children with early and continuously treated phenylketonuria (ECT-PKU) included in the databases Medline, PsycINFO, and PsycARTICLE. In addition to a classical approach, we summarized methodology and results of each study in order to discuss current theoretical and methodological issues. We also examined recent advances in biochemical markers and treatments of PKU, with implications for future research on metabolic control and its role as a determinant of neuropsychological outcome. Consistent with previous reviews, the hypothesis of a specific and central executive impairment in children with ECT-PKU was suggested. However, findings are inconclusive regarding the nature of executive impairments as well as their specificity, impact on everyday life, persistence over time, and etiology. Given the current state of the science, we suggest future directions for research that utilizes a developmental and integrative approach to examine the effects of recent advances in biochemical markers and treatment of PKU. (JINS, 2019, 25, 624-643).

UI MeSH Term Description Entries
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D056344 Executive Function A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD. Executive Control,Executive Controls,Executive Functions,Function, Executive,Functions, Executive
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
January 1992, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
December 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
October 2002, Neuroscience and biobehavioral reviews,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
July 1997, American journal of mental retardation : AJMR,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
October 2005, Pediatric neurology,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
September 1995, European journal of pediatrics,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
April 1996, Brain : a journal of neurology,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
April 2004, Developmental medicine and child neurology,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
May 2021, JIMD reports,
Marie Canton, and Didier Le Gall, and François Feillet, and Chrystele Bonnemains, and Arnaud Roy
December 2010, Journal of inherited metabolic disease,
Copied contents to your clipboard!